Save the Children, GlaxoSmithKline announce partnership

May 10, 2013 at 4:58 PM

LONDON, May 10 (UPI) -- Pharmaceuticals manufacturer GlaxoSmithKline and the Save the Children charity announced a partnership to develop medicines to combat child mortality in Africa.

The company said the partnership would set a new standard for how companies and charities can work together.

In reference to Save the Children, Andrew Witty, GlaxoSmithKline executive director, said: "For the first time we're involving a voice from an NGO (non-governmental organization) in our research and development agenda setting, for our pediatric development programs focused on the developing world. A partnership of this scale gives us an opportunity to do something amazing."

Flagship programs will begin in Kenya and the Democratic Republic of Congo, the company said in a release.

Witty said his firm expects to give about $23 million to Save the Children over the next several years.

Related UPI Stories
Latest Headlines
Trending Stories
One arrested after Philadelphia college lockdown
Boehner delays House vote for new speaker
NASA releases thousands of Apollo mission photos on Flickr
Snowden: U.S. won't respond to offers to serve prison time
FDA approves new treatment for advanced lung cancer